Handok

002390 · KOSPI · Health Care · SMALL CAP

Updated results.

Handok updated its previously filed provisional (unaudited) separate results for Q4 2025: revenue of US$92.7M (+13.64% year on year), operating profit of US$2.87M (from a loss a year earlier) and net income of US$9.34M (from a loss a year earlier).

Earnings([Amended] Operating results (preliminary) (fair disclosure))· FILED 2026-03-10· RCEPT 20260310802005

US$92.7MRevenue
+13.64%Revenue vs a year earlier
US$2.87MOperating profit

Converted at 1 USD ≈ ₩1,464.47 (filing-date rate, 2026-03-10 close)

What happened

Handok updated its previously filed provisional (unaudited) separate results for Q4 2025: revenue of US$92.7M (+13.64% year on year), operating profit of US$2.87M (from a loss a year earlier) and net income of US$9.34M (from a loss a year earlier).

These are preliminary figures the company disclosed ahead of its audited report; the final numbers can differ.

RevenueUS$92.7M
Revenue vs a year earlier+13.64%
Operating profitUS$2.87M
Net incomeUS$9.34M
PeriodQ4 2025 (separate)
Filed2026-03-10, [Amended] Operating results (preliminary) (fair disclosure)
SourceDART rcept 20260310802005 → open original filing

Versions of this filing

  1. 2026-02-10Original
  2. 2026-03-10Amendment 1 (this page)

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-03-10 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.